Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling
Creators
- 1. Department of Neurology, Taoyuan General Hospital, Ministry of Health and Welfare, Executive Yuan, Taiwan (China)
- 2. Department of Bioindustry Technology, Da-Yeh University, Taiwan (China)
- 3. Department of Biomedical Sciences, Chung Shan Medical University, Taiwan (China)
- 4. Department of Medical Research, Chung Shan Medical University Hospital, Taiwan (China)
Description
Cisplatin is a chemotherapeutic agent widely used in the treatment of various cancers. However, cisplatin can induce nephrotoxicity and neurotoxicity, limiting its dosage and usage. Galangin, a natural flavonol, has been found to exhibit anti-oxidant and anti-inflammatory effects in vivo. Here, we investigated the effects of galangin on cisplatin-induced acute kidney injury (AKI) and its molecular mechanisms in mice. Galangin administration reduced the cisplatin-induced oxidative stress by decreasing renal MDA and 3-NT formations. Galangin administration also increased renal anti-oxidative enzyme activities (SOD, GPx, and CAT) and GSH levels depleted by cisplatin. Furthermore, galangin administration inactivated stress-induced Nrf2 protein and its downstream products, HO-1 and GCLC. In terms of the inflammatory response, galangin administration reduced IκBα phosphorylation, NF-κB phosphorylation and nuclear translocation, and then inhibited cisplatin-induced secretions of pro-inflammatory TNF-α, IL-1β and IL-6. In addition, cisplatin-induced ERK and p38 phosphorylations were inhibited by galangin administration. In terms of cell death, galangin administration reduced levels of p53, pro-apoptotic Bax and activated caspase-3 to inhibit the cisplatin-induced apoptosis. Galangin administration also reduced the expression levels of RIP1 and RIP3 to inhibit cisplatin-induced RIP1/RIP3-dependent necroptosis. Therefore, galangin administration significantly ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation, and cell death through inhibitions of ERK and NF-κB signaling pathways. Galangin might be a potential adjuvant for clinical cisplatin therapy. - Highlights: • Galangin alleviates cisplatin-induced acute kidney injury through ERK and NF-kappaB signaling pathways. • Galangin reduces cisplatin-induced oxidative stress and inflammatory response. • Galangin suppresses cisplatin-induced cell death, apoptosis and necroptosis.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.taap.2017.05.034Additional details
Identifiers
- DOI
- 10.1016/j.taap.2017.05.034;
- PII
- S0041-008X(17)30240-5;
Publishing Information
- Journal Title
- Toxicology and Applied Pharmacology
- Journal Volume
- 329
- Journal Page Range
- p. 128-139
- ISSN
- 0041-008X
- CODEN
- TXAPA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49073700
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- APOPTOSIS; ENZYME ACTIVITY; INFLAMMATION; INHIBITION; KIDNEYS; MICE; OXIDATION; PHOSPHORUS 38; PHOSPHORYLATION; SIGNALS; STRESSES; SUPEROXIDE DISMUTASE
- Descriptors DEC
- ANIMALS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; CHEMICAL REACTIONS; ENZYMES; ISOTOPES; LIGHT NUCLEI; MAMMALS; MILLISECONDS LIVING RADIOISOTOPES; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANS; OXIDOREDUCTASES; PATHOLOGICAL CHANGES; PHOSPHORUS ISOTOPES; PROTEINS; RADIOISOTOPES; RODENTS; SYMPTOMS; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.